Breaking News Instant updates and real-time market news.

AOBC

American Outdoor Brands

$6.03

0.095 (1.60%)

, FEYE

FireEye

$13.84

-0.02 (-0.14%)

09:03
10/09/19
10/09
09:03
10/09/19
09:03

Fly Intel: Pre-market Movers

HIGHER: American Outdoor Brands (AOBC), up 7% after Craig-Hallum analyst Steven Dyer upgraded the stock to Buy from Hold, with an unchanged price target of $10... FireEye (FEYE), up 4% after revising Q3 revenue guidance... Roku (ROKU), up 3% after Macquarie analyst Tim Nollen upgraded shares to Outperform from Neutral with a price target of $130, up from $110. LOWER: James River Group (JRVR), down 9% after announcing that it delivered a notice of early cancellation, effective December 31, of all insurance policies issued to its largest customer, Rasier LLC and its affiliates... iRobot (IRBT), down 6% after Raymond James analyst Brian Gesuale downgraded the stock to Underperform from Market Perform, telling investors in a research note that he thinks Street models aren't reflecting the beginning of a meaningful commoditization cycle across the robotic vacuum category... Johnson & Johnson (JNJ), down 2% after Reuters reported that the company must pay $8B in punitive damages to a man who was previously awarded $680,000 over his claims that J&J failed to warn that young men using its antipsychotic drug Risperdal could grow breasts... Trinseo (TSE), down 2% after Citi analyst P.J. Juvekar downgraded shares to Sell from Neutral with a price target of $35, up from $32.

AOBC

American Outdoor Brands

$6.03

0.095 (1.60%)

FEYE

FireEye

$13.84

-0.02 (-0.14%)

ROKU

Roku

$108.06

1.615 (1.52%)

JRVR

James River Group

$48.96

-1.12 (-2.24%)

IRBT

iRobot

$57.40

-1.39 (-2.36%)

JNJ

Johnson & Johnson

$131.84

-1.32 (-0.99%)

TSE

Trinseo

$38.97

-0.54 (-1.37%)

  • 10

    Oct

  • 11

    Oct

  • 11

    Oct

  • 15

    Oct

  • 15

    Oct

  • 23

    Oct

  • 07

    Nov

  • 13

    Nov

  • 19

    Nov

AOBC American Outdoor Brands
$6.03

0.095 (1.60%)

09/06/19
KEYB
09/06/19
NO CHANGE
KEYB
Retail firearm background checks rose more than expected in August, says Keybanc
NICS background checks conducted by the FBI, which is a proxy for retail firearm demand, rose an adjusted 15.2% in August, according to Keybanc analyst Brett Andress. This was above his expectation for mid-single digit growth. State-level data also supports broad-based strength, with all but two states tracking positively, said the analyst, who added that comparisons ease further into September and October. Publicly traded companies in the gun space include American Outdoor Brands (AOBC), Sturm, Ruger (RGR), and Vista Outdoor (VSTO).
10/09/19
CHLM
10/09/19
UPGRADE
Target $10
CHLM
Buy
American Outdoor Brands upgraded to Buy from Hold at Craig-Hallum
Craig-Hallum analyst Steven Dyer upgraded American Outdoor Brands to Buy from Hold with an unchanged price target of $10.
10/09/19
10/09/19
UPGRADE
Target $10

Buy
American Outdoor Brands upgraded to Buy on valuation, catalysts at Craig-Hallum
As previously reported, Craig-Hallum analyst Steven Dyer upgraded American Outdoor Brands to Buy from Hold, with an unchanged price target of $10. The analyst believes valuation is "extremely attractive" and thinks there is a compelling near-term opportunity with potential catalysts upcoming even though he continues to have concerns about a potential longer-term secular decline in firearms.
08/30/19
LSCM
08/30/19
NO CHANGE
Target $14
LSCM
Buy
American Outdoor Brands price target lowered to $14 from $17 at Lake Street
Lake Street analyst Mark Smith lowered his price target for American Outdoor Brands to $14 from $17 after the company's Q1 results missed his estimates and consensus on the top and bottom lines. Management also gave a mixed message with Q2 guidance that was well below expectations while maintaining full-year revenue guidance and only bringing full-year earnings guidance down 6c due to tariffs, Smith tells investors in a research note. The analyst, however, thinks the shares are inexpensive and keeps a Buy rating on the name.
FEYE FireEye
$13.84

-0.02 (-0.14%)

10/03/19
DOTC
10/03/19
NO CHANGE
DOTC
FireEye exploring a sale 'would make a lot of sense,' says Dougherty
After it was reported that FireEye is exploring a possible sale to a private equity buyer, Dougherty analyst Catharine Trebnick said she was "not surprised" and that a sale would "make a lot of sense" given that the company is going through a transformation to cloud services. While the media report on the potential sale suggests the most likely buyer is a private equity firm, Trebnick thinks a strategic buyer - either one with a professional service segment seeking to expand its Federal presence or a buyer from the Federal side looking for a strong cyber security practice - could also be interested in acquiring FireEye. Trebnick has a Buy rating and $18 price target on FireEye shares, which gained 60c, or 4.5%, yesterday to close at $13.82.
10/02/19
RHCO
10/02/19
INITIATION
RHCO
SunTrust initiates infrastructure and security sector
SunTrust analyst Joel Fishbein initiated fourteen stocks in the infrastructure and security sector. Regarding infrastructure, he said he believes "we are in the 3rd inning of a multi year (even multi-decade) opportunity" and projected on-demand penetration of 70% by 2028, adding that "spending on cloud software is projected to grow at ~3x the overall software market rate, resulting in a greater than $208B market opportunity through 2025." However, Fishbein cautioned to "stay selective" as while he is bullish on the underlying trends, "too many investors are chasing too few stories." For cybersecurity, Fishbein noted that it remains a top priority for the corporations, and cited the IDC stating that "worldwide spending on security-related hardware, software, and services is forecast to reach $133.7B in 2022 at a compound annual growth rate of 9.9%." He believes that emerging vendors with innovative technology are growing much faster, and sees a "shift in spending from legacy security providers to next generation technology providers and multi-product platforms." The analyst started eight names with Buy ratings -- Atlassian (TEAM), New Relic (NEWR), ServiceNow (NOW), Splunk (SPLK), Palo Alto Networks (PANW), Rapid7 (RPD), SailPoint (SAIL), and Zscaler (ZS). The other six names Fishbein started with Hold ratings -- PagerDuty (PD), Check Point (CHKP), FireEye (FEYE), Proofpoint (PFPT), Qualys (QLYS), and Tenable Holdings (TENB).
10/02/19
RHCO
10/02/19
INITIATION
RHCO
Hold
FireEye initiated with a Hold at SunTrust
SunTrust analyst Joel Fishbein initiated Splunk with a Hold rating and $15 price target.
08/06/19
08/06/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. HarborOne Bancorp (HONE) initiated with a Buy at Janney Montgomery Scott. 2. Arvinas (ARVN) initiated with an Overweight at Cantor Fitzgerald. 3. EQT Midstream Partners (EQM) and Equitrans Midstream (ETRN) initiated with a Neutral at UBS. 4. One Stop Systems (OSS) transitioned with a Speculative Buy at Benchmark. 5. FireEye (FEYE) initiated with a Buy at Nomura Instinet. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
ROKU Roku
$108.06

1.615 (1.52%)

10/09/19
MACQ
10/09/19
UPGRADE
Target $130
MACQ
Outperform
Macquarie upgrades Roku to Outperform, sees tripling of sales by 2022
Macquarie analyst Tim Nollen upgraded Roku to Outperform from Neutral with a price target of $130, up from $110. The shares closed Tuesday up $1.75 to $108.00. The shift to connected television viewing that has been underway in the U.S. for the past few years will follow internationally in the coming years, Nollen tells investors in a research note. Roku has built a leading position in the U.S., and its devices will find a "ready market abroad," contends the analyst. However, he believes the bigger growth opportunity may be the company's smart TV operating system integrations. Nollen thinks Roku can grow its user base by three times to over 70M active accounts by 2022, from 31M currently. 72M subscribers by 2022 could drive Platform revenue to $2.3B and overall revenue of $2.7B, nearly tripling from 2019 guidance, says the analyst.
10/09/19
MACQ
10/09/19
UPGRADE
MACQ
Outperform
Roku upgraded to Outperform from Neutral at Macquarie
09/20/19
NEED
09/20/19
NO CHANGE
Target $150
NEED
Buy
Needham defends Roku, says competing successfully against media giants
Needham analyst Laura Martin commented on the recent weakness in Roku stock, telling investors in a research note that even if Roku's hardware sales "went to zero tomorrow," hardware sales represented a total of 5% of Roku's profit contribution and that the financial downside would be "minimal." Martin also argues that Roku's economic momentum is primarily driven by revenue share upside Roku will get from new SVOD services like Apple+ and Disney+ that must pay Roku to access their 30M OTT customers, and that Roku is a stronger competitor with more financial momentum and deeper moats, plus a well-established track record of competing successfully against media giants. She maintains a Buy rating and $150 price target on the stock.
09/20/19
09/20/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Roku (ROKU) initiated with a Sell at Pivotal Research. 2. Carvana (CVNA) initiated with an Outperform at Oppenheimer. 3. Zealand Pharma (ZEAL) and MyoKardia (MYOK) were initiated with a Buy at Guggenheim. 4. Wayfair (W) initiated with a Sell at Berenberg. 5. Eton Pharmaceuticals (ETON) initiated with a Buy at B. Riley FBR. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
JRVR James River Group
$48.96

-1.12 (-2.24%)

10/09/19
10/09/19
DOWNGRADE
Target $40

Hold
James River Group downgraded to Hold from Buy at SunTrust
As previously reported, SunTrust analyst Mark Hughes downgraded James River Group (JRVR) to Hold and lowered his price target to $40 from $55 after the company's announcement that it will increase its reserves by up to $60M this quarter to account for commercial auto line of business losses as well as its ended Uber (UBER) relationship this year. As Uber reserves continue to develop adversely, the analyst is also lowering his FY20 EPS view on James River to $1.35 from $3.00, reflecting new assumptions about the company's profitability.
10/09/19
RILY
10/09/19
DOWNGRADE
Target $40
RILY
Sell
James River Group downgraded to Sell from Neutral at B. Riley FBR
B. Riley FBR analyst Randy Binner downgraded James River Group to Sell from Neutral with a $40 price target, down from $45. The analyst is negative on the shares following last night's announcement of an commercial auto charge.
10/09/19
RHCO
10/09/19
DOWNGRADE
Target $40
RHCO
Hold
James River Group downgraded to Hold from Buy at SunTrust
SunTrust analyst Mark Hughes downgraded James River Group to Hold from Buy with a price target of $40, down from $55.
10/09/19
RILY
10/09/19
DOWNGRADE
Target $40
RILY
Sell
B. Riley FBR downgrades James River Group to Sell on Uber termination
James River Group Holdings (JRVR) disclosed last night that it plans to cancel all policies issued to its largest customer, Uber (UBER) commercial auto business Raiser LLC, effective December 31, 2019, due to unfavorable loss experience, B. Riley FBR analyst Randy Binner tells investors in a research note. While the reserve charge is manageable, concern around reserve adequacy is likely to remain an overhang on James River shares given the termination of the Uber relationship, a "significant move," says Binner. The analyst believes James River shares "will re-rate to a lower multiple to book value." He downgraded the stock to Sell from Neutral and cut his price target for the shares to $40 from $45.
IRBT iRobot
$57.40

-1.39 (-2.36%)

09/27/19
BOFA
09/27/19
INITIATION
Target $70
BOFA
Buy
iRobot initiated with a Buy at BofA/Merrill
BofA/Merrill analyst John Babcock initiated iRobot with a Buy rating and a price target of $70. The analyst notes that the valuation on the stock at 17.9-times his expected 2020 earnings is "relatively attractive" while investor sentiment is "relatively negative", saying that its near term results are likely to "surprise positively". Babcock adds that while his FY20 earnings projection is below consensus, expecting estimates to come down, he believes that is already priced into the shares.
10/04/19
PIPR
10/04/19
NO CHANGE
Target $64
PIPR
Neutral
iRobot price target lowered to $64 from $75 at Piper Jaffray
Piper Jaffray analyst Troy Jensen lowered his price target for iRobot to $64 from $75 ahead of the company's Q3 results and reiterates a Neutral rating on the shares. 2019 has shaped up to be a "challenging year" for iRobot with increased tariffs resulting in higher average selling prices and now a "new, formidable competitor" in Shark at the higher end segment of the market, Jensen tells investors in a research note. While Q4 is typically a "slam dunk quarter" for the company, this year will be more challenging, adds the analyst. As such, Jensen prefers to take a "wait and see approach" with respect the stock.
10/09/19
RAJA
10/09/19
DOWNGRADE
RAJA
Underperform
Raymond James cites emergence of pricing war in iRobot downgrade
Raymond James analyst Brian Gesuale downgraded iRobot to Underperform from Market Perform, telling investors in a research note that he thinks Street models aren't reflecting the beginning of a meaningful commoditization cycle across the RVC category. As growth rates and profits decelerate and its workhorse product, the Roomba, is finally feeling "fatigue" after 17 years of service.
10/09/19
RAJA
10/09/19
DOWNGRADE
RAJA
Underperform
iRobot downgraded to Underperform from Market Perform at Raymond James
Raymond James analyst Brian Gesuale downgraded to Underperform from Market Perform citing the emergence of a pricing war.
JNJ Johnson & Johnson
$131.84

-1.32 (-0.99%)

10/02/19
WELS
10/02/19
NO CHANGE
WELS
Outperform
J&J Ohio settlements suggest 'manageable' liability, says Wells Fargo
Wells Fargo analyst Larry Biegelsen notes that Johnson & Johnson has announced a settlement agreement with the Ohio counties of Cuyahoga and Summit that resolves all of the counties' claims with no admission of liability and removes the company from the federal trial scheduled to begin October 21, 2019 for a total of $20.4M. The analyst notes that after applying the total settlement amount to the populations of Cuyahoga and Summit counties and that to the total U.S. population of 327M, he arrives at a total settlement amount of $3.7B, which is well below his expected total settlement amount of $10B-$15B. Importantly, Biegelsen expects any settlement amount to be paid over a period of many years which will make the potential payments more manageable for Johnson & Johnson. He has an Outperform rating on the shares.
08/27/19
JPMS
08/27/19
NO CHANGE
JPMS
Neutral
Johnson & Johnson verdict well below feared worst case, says JPMorgan
The $572M verdict against Johnson & Johnson in Oklahoma came in well below the feared worst case, as investor expectations for the verdict increased over the past few weeks to over $1B, JPMorgan analyst Chris Schott tells investors in a research note. Further, the analyst believes the company has "strong legal grounding" to potentially overturn and/or reduce the verdict. Nonetheless, Schott still sees a more balanced risk/reward near-term for J&J shares and remain on the sidelines with a Neutral rating.
08/27/19
FBCO
08/27/19
NO CHANGE
Target $156
FBCO
Outperform
Opioid ruling reduces uncertainty, helps J&J move higher, says Credit Suisse
Credit Suisse analyst Matt Miksic notes that Johnson & Johnson appeared to react favorably to Oklahoma opioid ruling, due in part, to the $572M penalty being substantially lower than the $17B sought by State prosecutors. The analyst believes the decision helped reduce the range of uncertainty related to the potential opioid-related liability Johnson & Johnson could face, specifically in Oklahoma, if not across the U.S. more broadly. Miksic reiterates an Outperform rating and $156 target on the shares.
08/27/19
WELS
08/27/19
NO CHANGE
WELS
Outperform
Opioid ruling should assuage Johnson & Johnson investor fears, says Wells Fargo
Wells Fargo analyst Larry Biegelsen thinks decision in Oklahoma is a net positive for Johnson & Johnson in that the amount the judge ordered the company to pay - $572M - was well below the amount the plaintiffs requested - $17.5B. Further, the analyst notes that the amount was for abatement of the entire opioid crisis in Oklahoma, not just Johnson & Johnson's share of it, which seems like something the company should be able to overturn or reduce on appeal. Although J&J plans to appeal the ruling, Biegelsen expects the company to eventually settle this and other opioid cases. Big picture, he estimates Johnson & Johnson will eventually settle the opioid litigation for between $5B-10B payable over several years which admittedly is a rough guess at this time. He has an Outperform rating on the shares.
TSE Trinseo
$38.97

-0.54 (-1.37%)

09/26/19
DBAB
09/26/19
NO CHANGE
Target $50
DBAB
Buy
Trinseo price target raised to $50 from $38 at Deutsche Bank
Deutsche Bank analyst David Begleiter raised his price target for Trinseo to $50 from $38 citing recent peer group multiple expansion. Chemical multiples have expanded on the rotation into value stocks from momentum stocks, short-term benefits on petrochemicals as a result of higher oil prices on a series of drone/cruise missile attacks on Saudi Arabia's oil production facilities, and improving sentiment around the U.S.-China trade dispute, Begleiter tells investors in a research note. He maintains a Buy rating on the shares.
08/12/19
DBAB
08/12/19
NO CHANGE
Target $38
DBAB
Buy
Trinseo post earnings selloff Friday overdone, says Deutsche Bank
Deutsche Bank analyst David Begleiter lowered his price target for Trinseo to $38 from $50 but says Friday's post earnings selloff in shares is overdone. The guidance reduction was expected due to "well flagged" headwinds including a near quarter long outage at the company's styrene plant in Boehlen, and the low end of the range now appears conservative, Begleiter tells investors in a research note. He keeps a Buy rating on Trinseo shares.
08/13/19
SBSH
08/13/19
DOWNGRADE
Target $32
SBSH
Neutral
Trinseo downgraded to Neutral from Buy at Citi
Citi analyst Eric Petrie downgraded Trinseo to Neutral from Buy and lowered his price target for the shares to $32 from $48. The analyst cites new styrene capacity and lower derivative demand for the downgrade. As such, the analyst sees a lack of catalysts for the stock in the current macro backdrop amid trade uncertainty.
10/09/19
SBSH
10/09/19
DOWNGRADE
Target $35
SBSH
Sell
Trinseo downgraded to Sell from Neutral at Citi
Citi analyst P.J. Juvekar downgraded Trinseo to Sell from Neutral with a price target of $35, up from $32. The third quarter for Chemicals felt like a continuation of the second quarter, with weak autos and construction activity as well as slowing global trade, Juvekar tells investors in a research note. The analyst has turned cautious on chlor-alkali and has moved to the sidelines on the chlor-alkali chain. Although there is not much capacity on the horizon, demand has been softer this year and is unlikely to pick up, contends Juvekar.

TODAY'S FREE FLY STORIES

HEXO

Hexo

$2.54

-0.05 (-1.93%)

12:45
10/23/19
10/23
12:45
10/23/19
12:45
Hot Stocks
Breaking Hot Stocks news story on Hexo 

Hexo Corp trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 12

    Nov

  • 12

    Nov

NLY

Annaly Capital

$8.94

0.05 (0.56%)

12:45
10/23/19
10/23
12:45
10/23/19
12:45
Options
Annaly Capital call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

INTC

Intel

$51.83

-0.175 (-0.34%)

, SFTBF

SoftBank

$0.00

(0.00%)

12:44
10/23/19
10/23
12:44
10/23/19
12:44
Periodicals
Intel files suit against SoftBank's Fortress over patents, Reuters says »

Intel (INTC) has filed an…

INTC

Intel

$51.83

-0.175 (-0.34%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 20

    Nov

C

Citi

$72.11

0.03 (0.04%)

12:42
10/23/19
10/23
12:42
10/23/19
12:42
Periodicals
Judge says Citi claim against Czech miner OKD is eligible, Reuters says »

A Czech court determined…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 12

    Nov

  • 14

    Jan

ALXN

Alexion

$105.68

6.46 (6.51%)

12:40
10/23/19
10/23
12:40
10/23/19
12:40
Recommendations
Alexion analyst commentary  »

Piper a buyer of Alexion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 04

    Nov

  • 07

    Dec

SHI

Sinopec Shanghai

$28.18

-0.44 (-1.54%)

12:40
10/23/19
10/23
12:40
10/23/19
12:40
Upgrade
Sinopec Shanghai rating change  »

Sinopec Shanghai upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:40
10/23/19
10/23
12:40
10/23/19
12:40
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

SFTBF

SoftBank

$0.00

(0.00%)

, WE

We Company

$0.00

(0.00%)

12:38
10/23/19
10/23
12:38
10/23/19
12:38
Periodicals
WeWork's Claure tells staff layoffs are in the works, Reuters says »

Marcelo Claure,…

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$53.89

-0.55 (-1.01%)

, RHHBY

Roche

$0.00

(0.00%)

12:36
10/23/19
10/23
12:36
10/23/19
12:36
Periodicals
Trump to nominate Stephen Hahn as FDA commissioner, WSJ reports »

President Trump intends…

BMY

Bristol-Myers

$53.89

-0.55 (-1.01%)

RHHBY

Roche

$0.00

(0.00%)

NVS

Novartis

$86.51

-0.32 (-0.37%)

GSK

GlaxoSmithKline

$43.27

0.76 (1.79%)

AZN

AstraZeneca

$44.61

0.69 (1.57%)

SNY

Sanofi

$45.54

0.23 (0.51%)

PFE

Pfizer

$36.63

0.19 (0.52%)

MRK

Merck

$82.39

1.09 (1.34%)

LLY

Eli Lilly

$106.97

-3.03 (-2.75%)

JNJ

Johnson & Johnson

$130.13

0.95 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 26

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 04

    Nov

  • 06

    Nov

  • 06

    Nov

  • 08

    Nov

  • 11

    Nov

  • 12

    Nov

  • 18

    Nov

  • 07

    Dec

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

HEXO

Hexo

$2.54

-0.05 (-1.93%)

12:32
10/23/19
10/23
12:32
10/23/19
12:32
Syndicate
Hexo announces C$70M private placement of convertible debentures »

Hexo Corp announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 12

    Nov

  • 12

    Nov

CRM

Salesforce

$145.02

2.75 (1.93%)

12:30
10/23/19
10/23
12:30
10/23/19
12:30
Options
Heavy delta short term call buyer in Salesforce »

Heavy delta short term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

DYMEF

DionyMed Brands

$0.00

(0.00%)

12:29
10/23/19
10/23
12:29
10/23/19
12:29
Hot Stocks
DionyMed Brands receives court application seeking to appoint receiver »

DionyMed Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMG

Chipotle

$785.08

-46.605 (-5.60%)

12:29
10/23/19
10/23
12:29
10/23/19
12:29
Periodicals
Hedgeye sees 30% downside in Chipotle, adds to Best Idea Short List 

Reported by Bloomberg.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

BA

Boeing

$340.95

3.5 (1.04%)

, CAT

Caterpillar

$133.30

-0.39 (-0.29%)

12:28
10/23/19
10/23
12:28
10/23/19
12:28
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been a bit…

BA

Boeing

$340.95

3.5 (1.04%)

CAT

Caterpillar

$133.30

-0.39 (-0.29%)

TXN

Texas Instruments

$120.05

-8.56 (-6.66%)

LLY

Eli Lilly

$106.95

-3.05 (-2.77%)

FB

Facebook

$184.57

2.3 (1.26%)

ADI

Analog Devices

$106.03

-4.88 (-4.40%)

MCHP

Microchip

$93.22

-3.09 (-3.21%)

XLNX

Xilinx

$94.81

-1.2 (-1.25%)

NXPI

NXP Semiconductors

$104.12

-3.62 (-3.36%)

TNK

Teekay Tankers

$2.21

0.22 (11.06%)

WGO

Winnebago

$46.96

4.17 (9.75%)

TMO

Thermo Fisher

$296.86

15.97 (5.69%)

SNAP

Snap

$13.22

-0.78 (-5.57%)

REZI

Resideo

$9.06

-6.11 (-40.28%)

LRN

K12

$20.03

-4.81 (-19.36%)

CMG

Chipotle

$784.15

-47.535 (-5.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 04

    Nov

  • 05

    Nov

  • 06

    Nov

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

  • 20

    Nov

  • 21

    Nov

  • 02

    Dec

  • 07

    Dec

SPLK

Splunk

$117.82

7.41 (6.71%)

12:25
10/23/19
10/23
12:25
10/23/19
12:25
Options
Splunk call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$297.03

16.14 (5.75%)

12:23
10/23/19
10/23
12:23
10/23/19
12:23
Recommendations
Thermo Fisher analyst commentary  »

Thermo Fisher price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

  • 02

    Dec

  • 07

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
10/23/19
10/23
12:17
10/23/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
10/23/19
10/23
12:16
10/23/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$17.60

-0.27 (-1.51%)

12:15
10/23/19
10/23
12:15
10/23/19
12:15
Options
Gap put volume heavy and directionally bearish »

Bearish flow noted in Gap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

PYPL

PayPal

$95.85

-1.55 (-1.59%)

, SYF

Synchrony

$34.88

-0.1 (-0.29%)

12:14
10/23/19
10/23
12:14
10/23/19
12:14
Earnings
Fly Intel: What to watch in PayPal earnings report »

PayPal (PYPL) is…

PYPL

PayPal

$95.85

-1.55 (-1.59%)

SYF

Synchrony

$34.88

-0.1 (-0.29%)

V

Visa

$171.35

0.46 (0.27%)

MA

MasterCard

$260.61

-0.69 (-0.26%)

FB

Facebook

$184.50

2.23 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 21

    Nov

F

Ford

$9.04

-0.025 (-0.28%)

12:00
10/23/19
10/23
12:00
10/23/19
12:00
Options
Large pre-earnings calendar spread in Ford ahead of earnings »

Large pre-earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

TXN

Texas Instruments

$120.29

-8.32 (-6.47%)

11:50
10/23/19
10/23
11:50
10/23/19
11:50
Options
Aggressive post-earnings put seller in Texas Instruments »

Aggressive post-earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBTC

Bitcoin Investment Trust

$0.00

(0.00%)

, FB

Facebook

$185.39

3.12 (1.71%)

11:48
10/23/19
10/23
11:48
10/23/19
11:48
Periodicals
Bitcoin falls amid Zuckerberg testimony on Facebook's Libra, Bloomberg says »

Bloomberg's Claire…

GBTC

Bitcoin Investment Trust

$0.00

(0.00%)

FB

Facebook

$185.39

3.12 (1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

SPY

SPDR S&P 500 ETF Trust

$299.50

0.47 (0.16%)

, SPX

S&P 500

$0.00

(0.00%)

11:47
10/23/19
10/23
11:47
10/23/19
11:47
General news
President Trump says lifting sanctions on Turkey with ceasefire to be permanent »

President Trump announced…

SPY

SPDR S&P 500 ETF Trust

$299.50

0.47 (0.16%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZS

Zscaler

$41.57

0.84 (2.06%)

11:45
10/23/19
10/23
11:45
10/23/19
11:45
Options
Zscaler call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.